Clinical Trial Update: Comparative Evaluation of Pharmacokinetics After CKD-501 Between Renal Impaired and Normal Renal Function Subjects [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic comparison of CKD-501 in subjects with renal impairment versus healthy controls to assess the impact of kidney function on drug exposure…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Renal Impairment

Drugs mentioned

• CKD-501

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Renal Impairment, Healthy | Phase 1 | Status: COMPLETED